Yaky Yanay
Overview
Yaky Yanay received an average of $2M in total compensation, including $293K in salary, at Pluristem Therapeutics from 2008 to 2023.
2023Pluristem TherapeuticsCEO
2022Pluristem TherapeuticsChief Executive Officer
2021Pluristem TherapeuticsChief Executive Officer
2020Pluristem TherapeuticsCEO
2019Pluristem TherapeuticsChief Executive Officer
2018Pluristem TherapeuticsCo, CEO and President
2017Pluristem TherapeuticsCo, CEO and President
2016Pluristem TherapeuticsCo, CEO and President
2015Pluristem TherapeuticsCo, CEO and President
2014Pluristem TherapeuticsCo, CEO and President
Source: SEC filings on May 1, 2024, February 27, 2023, April 8, 2021, May 20, 2020, April 25, 2019, April 3, 2018, March 30, 2017, March 31, 2014, March 29, 2013, March 22, 2012, April 15, 2011, and November 23, 2009.
Related executives
We found three more executives who work or worked at Pluristem Therapeutics.
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019